Vous n'êtes pas identifié (connexion)

Centre de recherche

MERCREDI 22 NOV

Calendrier >

BOTTIN

François Rousseau

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Santé des populations et pratiques optimales en santé
Adresse(s)
Hôpital Saint-François-d'Assise
10, rue de l'Espinay
A2-222
Québec (Québec)
CANADA G1L 3L5

Téléphone(s)
+1 418-525-4470
Télécopieur(s)
+1 418-525-4195
Courriel(s)
francois.rousseau@mac.com

Publications récentes (voir toutes les publications de ce chercheur)

Fagete S, Botas-Perez L, Rossito-Borlat I, Adea K, Gueneau F, Ravn U, Rousseau F, Kosco-Vilbois M, Fischer N, Hartley O. Dual display: phage selection driven by co-engagement of two targets by two different antibody fragments. Protein engineering, design & selection : PEDS ,  2017. Epub
Wilson BJ, Miller FA, Rousseau F. Clinical genomic sequencing as a routine technology for case finding and diagnosis in unselected patient populations should not proceed without formal comparative evaluation of health outcomes and system impacts. Journal of clinical epidemiology,  2017. Epub
Ravitsky V, Rousseau F, Laberge AM. Providing Unrestricted Access to Prenatal Testing Does Not Translate to Enhanced Autonomy. The American journal of bioethics : AJOB,  2017. 17: 39-41
Portocarrero ME, Giguere AM, Lepine J, Garvelink MM, Robitaille H, Delanoe A, Levesque I, Wilson BJ, Rousseau F, Legare F. Use of a patient decision aid for prenatal screening for Down syndrome: what do pregnant women say? BMC pregnancy and childbirth,  2017. Epub
Rivera B, Di Iorio M, Frankum J, Nadaf J, Fahiminiya S, Arcand SL, Burk DL, Grapton D, Tomiak E, Hastings V, Hamel N, Wagener R, Aleynikova O, Giroux S, Hamdan FF, Dionne-Laporte A, Zogopoulos G, Rousseau F, Berghuis AM, Provencher D, Rouleau GA, Michaud JL, Mes-Masson AM, Majewski J, Bens S, Siebert R, Narod SA, Akbari MR, Lord CJ, Tonin PN, Orthwein A, Foulkes WD. Functionally Null RAD51D Missense Mutation Associates Strongly with Ovarian Carcinoma. Cancer research,  2017. 77: 4517-4529
Nshimyumukiza L, Beaumont JA, Duplantie J, Langlois S, Little J, Audibert F, McCabe C, Gekas J, Giguere Y, Gagne C, Reinharz D, Rousseau F. Cell-Free DNA-Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC,  2017. Epub
Payne DA, Baluchova K, Peoc'h KH, van Schaik RH, Chan KC, Maekawa M, Mamotte C, Russomando G, Rousseau F, Ahmad-Nejad P, IFCC Committee for Molecular Diagnostics (C-MD). Pre-examination factors affecting molecular diagnostic test results and interpretation: A case-based approach. Clinica chimica acta; international journal of clinical chemistry,  2017. 467: 59-69
Murdoch B, Ravitsky V, Ogbogu U, Ali-Khan S, Bertier G, Birko S, Bubela T, De Beer J, Dupras C, Ellis M, Granados Moreno P, Joly Y, Kamenova K, Master Z, Marcon A, Paulden M, Rousseau F, Caulfield T. Non-invasive Prenatal Testing and the Unveiling of an Impaired Translation Process. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC,  2017. 39: 10-17
Nshimyumukiza L, Menon S, Hina H, Rousseau F, Reinharz D. Cell-free DNA noninvasive prenatal screening for aneuploidy versus conventional screening: a systematic review of economic evaluations. Clinical genetics,  2017. Epub
Wilson BJ, Miller FA, Rousseau F. Controversy and debate on clinical genomics sequencing-paper 3: response to "clinical genome-wide sequencing: do not throw out the baby with the bathwater". Journal of clinical epidemiology,  2017. Epub
© 2017 Tous droits réservés Centre de recherche du CHU de Québec